IceCure Medical (ICCM) Stock Forecast, Price Target & Predictions
ICCM Stock Forecast
IceCure Medical stock forecast is as follows: an average price target of $5.75 (represents a 945.45% upside from ICCM’s last price of $0.55) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ICCM Price Target
The average price target for IceCure Medical (ICCM) is $5.75 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $5.75 to $5.75. This represents a potential 945.45% upside from ICCM's last price of $0.55.
ICCM Analyst Ratings
According to 2 Wall Street analysts, IceCure Medical's rating consensus is 'Buy'. The analyst rating breakdown for ICCM stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
IceCure Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 19, 2022 | Ben Haynor | Industrial Alliance Securities | $5.75 | $1.88 | 205.85% | 945.45% |
The latest IceCure Medical stock forecast, released on May 19, 2022 by Ben Haynor from Industrial Alliance Securities, set a price target of $5.75, which represents a 205.85% increase from the stock price at the time of the forecast ($1.88), and a 945.45% increase from ICCM last price ($0.55).
IceCure Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.55 | $0.55 | $0.55 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of IceCure Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to IceCure Medical's last price of $0.55. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 19, 2022 | Alliance Global Partners | Buy | Buy | Hold |
IceCure Medical's last stock rating was published by H.C. Wainwright on Sep 13, 2024. The company gave ICCM a "Buy" rating, the same as its previous rate.
IceCure Medical Financial Forecast
IceCure Medical Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | $710.00K |
| Avg Forecast | $2.04M | $1.44M | $1.41M | $952.50K | $1.29M | $708.50K | $925.50K | $1.02M | $1.17M | $1.02M | $934.33K | $950.00K |
| High Forecast | $2.04M | $1.44M | $1.41M | $952.50K | $1.29M | $708.50K | $925.50K | $1.02M | $1.17M | $1.02M | $934.33K | $950.00K |
| Low Forecast | $2.04M | $1.44M | $1.41M | $952.50K | $1.29M | $708.50K | $925.50K | $1.02M | $1.17M | $1.02M | $934.33K | $950.00K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.75% |
IceCure Medical's average Quarter revenue forecast for Jun 23 based on 1 analysts is $934.33K, with a low forecast of $934.33K, and a high forecast of $934.33K. ICCM's average Quarter revenue forecast represents a 31.60% increase compared to the company's last Quarter revenue of $710.00K (Mar 23).
IceCure Medical EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | $-3.88M |
| Avg Forecast | $-2.04M | $-1.44M | $-1.41M | $-952.50K | $-1.29M | $-708.50K | $-925.50K | $-1.02M | $-1.17M | $-1.02M | $-934.33K | $-950.00K |
| High Forecast | $-2.04M | $-1.44M | $-1.41M | $-952.50K | $-1.29M | $-708.50K | $-925.50K | $-1.02M | $-1.17M | $-1.02M | $-934.33K | $-950.00K |
| Low Forecast | $-2.04M | $-1.44M | $-1.41M | $-952.50K | $-1.29M | $-708.50K | $-925.50K | $-1.02M | $-1.17M | $-1.02M | $-934.33K | $-950.00K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 4.08% |
undefined analysts predict ICCM's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than IceCure Medical's previous annual EBITDA (undefined) of $NaN.
IceCure Medical Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | $-3.58M |
| Avg Forecast | $-2.95M | $-2.95M | $-2.95M | $-3.45M | $-3.45M | $-3.69M | $-3.45M | $-3.77M | $-3.45M | $-4.43M | $-4.27M | $-4.59M |
| High Forecast | $-2.95M | $-2.95M | $-2.95M | $-3.45M | $-3.45M | $-3.69M | $-3.45M | $-3.77M | $-3.45M | $-4.43M | $-4.27M | $-4.59M |
| Low Forecast | $-2.95M | $-2.95M | $-2.95M | $-3.45M | $-3.45M | $-3.69M | $-3.45M | $-3.77M | $-3.45M | $-4.43M | $-4.27M | $-4.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.78% |
IceCure Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ICCM's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
IceCure Medical SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | $2.17M |
| Avg Forecast | $3.74M | $2.65M | $2.58M | $1.75M | $2.37M | $1.30M | $1.70M | $1.87M | $2.14M | $1.87M | $1.71M | $1.74M |
| High Forecast | $3.74M | $2.65M | $2.58M | $1.75M | $2.37M | $1.30M | $1.70M | $1.87M | $2.14M | $1.87M | $1.71M | $1.74M |
| Low Forecast | $3.74M | $2.65M | $2.58M | $1.75M | $2.37M | $1.30M | $1.70M | $1.87M | $2.14M | $1.87M | $1.71M | $1.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.24% |
IceCure Medical's average Quarter SG&A projection for Jun 23 is $1.71M, based on 1 Wall Street analysts, with a range of $1.71M to $1.71M. The forecast indicates a -20.85% fall compared to ICCM last annual SG&A of $2.17M (Mar 23).
IceCure Medical EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | $-0.08 |
| Avg Forecast | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | $-0.08 | $-0.07 | $-0.09 | $-0.09 | $-0.09 |
| High Forecast | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | $-0.08 | $-0.07 | $-0.09 | $-0.09 | $-0.09 |
| Low Forecast | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | $-0.08 | $-0.07 | $-0.09 | $-0.09 | $-0.09 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.84% |
According to undefined Wall Street analysts, IceCure Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ICCM previous annual EPS of $NaN (undefined).
IceCure Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ICCM | IceCure Medical | $0.55 | $5.75 | 945.45% | Buy |
| CTSO | Cytosorbents | $0.93 | $9.00 | 867.74% | - |
| TELA | TELA Bio | $3.06 | $12.50 | 308.50% | Buy |
| SGHT | Sight Sciences | $3.98 | $9.00 | 126.13% | Hold |
| ESTA | Establishment Labs | $39.32 | $78.00 | 98.37% | Buy |
| KIDS | OrthoPediatrics | $24.26 | $39.60 | 63.23% | Buy |
| NPCE | NeuroPace | $9.15 | $12.88 | 40.77% | Buy |
| CNMD | CONMED | $75.65 | $96.00 | 26.90% | Buy |
| BWAY | BrainsWay | $9.04 | $10.00 | 10.62% | Buy |
| CLPT | ClearPoint Neuro | $10.95 | $12.00 | 9.59% | Buy |
| SRDX | Surmodics | $38.17 | $39.50 | 3.48% | Buy |
| ITGR | Integer | $137.56 | $138.00 | 0.32% | Buy |